Losing DNA methylation at repetitive elements and breaking bad

XG Pappalardo, V Barra - Epigenetics & chromatin, 2021 - Springer
Background DNA methylation is an epigenetic chromatin mark that allows heterochromatin
formation and gene silencing. It has a fundamental role in preserving genome stability …

Novel insights into the molecular mechanisms of atherosclerosis

A Wojtasińska, W Frąk, W Lisińska, N Sapeda… - International journal of …, 2023 - mdpi.com
Atherosclerosis is one of the most fatal diseases in the world. The associated thickening of
the arterial wall and its background and consequences make it a very composite disease …

Nicotinamide mononucleotide (NMN) supplementation promotes anti-aging miRNA expression profile in the aorta of aged mice, predicting epigenetic rejuvenation …

T Kiss, CB Giles, S Tarantini, A Yabluchanskiy… - Geroscience, 2019 - Springer
Understanding molecular mechanisms involved in vascular aging is essential to develop
novel interventional strategies for treatment and prevention of age-related vascular …

[HTML][HTML] Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling

W Shen, C Gao, R Cueto, L Liu, H Fu, Y Shao… - Redox biology, 2020 - Elsevier
Homocysteine-Methionine (HM) cycle produces universal methyl group donor S-
adenosylmethione (SAM), methyltransferase inhibitor S-adenosylhomocysteine (SAH) and …

From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases

U Landmesser, W Poller, S Tsimikas… - European heart …, 2020 - academic.oup.com
Nucleic acid-based therapeutics are currently developed at large scale for prevention and
management of cardiovascular diseases (CVDs), since:(i) genetic studies have highlighted …

Vulnerable atherosclerotic plaque: is there a molecular signature?

RM Chiorescu, M Mocan, AI Inceu, AP Buda… - International Journal of …, 2022 - mdpi.com
Atherosclerosis and its clinical manifestations, coronary and cerebral artery diseases, are
the most common cause of death worldwide. The main pathophysiological mechanism for …

DNA methylation aberrant in atherosclerosis

Y Dai, D Chen, T Xu - Frontiers in Pharmacology, 2022 - frontiersin.org
Atherosclerosis (AS) is a pathological process involving lipid oxidation, immune system
activation, and endothelial dysfunction. The activated immune system could lead to …

Excess S-adenosylmethionine inhibits methylation via catabolism to adenine

K Fukumoto, K Ito, B Saer, G Taylor, S Ye… - Communications …, 2022 - nature.com
The global dietary supplement market is valued at over USD 100 billion. One popular dietary
supplement, S-adenosylmethionine, is marketed to improve joints, liver health and …

DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy

L Zhang, C Xia, Y Yang, F Sun, Y Zhang… - Cell Communication and …, 2023 - Springer
Atherosclerosis, which is a vascular pathology characterized by inflammation and plaque
build-up within arterial vessel walls, acts as the important cause of most cardiovascular …

[HTML][HTML] The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level

AT Davletgildeeva, NA Kuznetsov - Biomolecules, 2024 - mdpi.com
This review deals with the functional characteristics and biological roles of enzymes
participating in DNA methylation and demethylation as key factors in epigenetic regulation of …